{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:33:15Z","timestamp":1793305995425,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijantimicag.2026.108018","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:35:29Z","timestamp":1790836529000},"page":"108018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of P-CABs-based bismuth quadruple therapy for first-line Helicobacter pylori eradication: A real-world evidence study"],"prefix":"10.1016","volume":"67","author":[{"given":"Kunping","family":"Ju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruili","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baobao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4744-3269","authenticated-orcid":false,"given":"Qingzhou","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7042-9695","authenticated-orcid":false,"given":"Yueyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.108018_bib0001","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","article-title":"Helicobacter pylori infection","volume":"9","author":"Malfertheiner","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ijantimicag.2026.108018_bib0002","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1038\/s41591-024-03153-w","article-title":"Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial","volume":"30","author":"Pan","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.ijantimicag.2026.108018_bib0003","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.gastro.2023.09.047","article-title":"Evolving concepts in Helicobacter pylori management","volume":"166","author":"Moss","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijantimicag.2026.108018_bib0004","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2544886","article-title":"Research progress of potassium-competitive acid blockers in the treatment of Helicobacter pylori","volume":"57","author":"Ma","year":"2025","journal-title":"Ann Med"},{"key":"10.1016\/j.ijantimicag.2026.108018_bib0005","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.14309\/ajg.0000000000002968","article-title":"ACG Clinical Guideline: treatment of Helicobacter pylori infection","volume":"119","author":"Chey","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ijantimicag.2026.108018_bib0006","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","volume":"71","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ijantimicag.2026.108018_bib0007","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2026.108018_bib0008","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40265-023-01991-5","article-title":"Vonoprazan: a review in Helicobacter pylori infection","volume":"84","author":"Shirley","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2026.108018_bib0009","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13150","article-title":"Comparative efficacy and safety of potassium-competitive acid blockers and proton pump inhibitors for first-line Helicobacter pylori eradication therapy: a systematic review and network meta-analysis","volume":"29","author":"Ouyang","year":"2024","journal-title":"Helicobacter"},{"key":"10.1016\/j.ijantimicag.2026.108018_bib0010","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1007\/s10620-024-08460-3","article-title":"Bismuth-containing quadruple therapy for Helicobacter pylori eradication: a randomized clinical trial of 10 and 14 days","volume":"69","author":"Ding","year":"2024","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ijantimicag.2026.108018_bib0011","doi-asserted-by":"crossref","DOI":"10.1111\/hel.70036","article-title":"Seven-day versus 14-day tegoprazan and tetracycline-containing quadruple therapy for first-line eradication of Helicobacter pylori infection: a randomized, open-label, Noninferiority Trial","volume":"30","author":"Nan","year":"2025","journal-title":"Helicobacter"},{"key":"10.1016\/j.ijantimicag.2026.108018_bib0012","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12953","article-title":"Impact of body size on efficacy of high-dose dual therapy for Helicobacter pylori eradication","volume":"28","author":"Guan","year":"2023","journal-title":"Helicobacter"},{"key":"10.1016\/j.ijantimicag.2026.108018_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(25)02725-8","article-title":"Su1476: optimizing H. pylori eradication in obese patients: the impact of weight-adjusted quadruple therapy","volume":"169","author":"Laudanno","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijantimicag.2026.108018_bib0014","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1097\/CM9.0000000000002546","article-title":"2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment","volume":"135","author":"Zhou","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ijantimicag.2026.108018_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107325","article-title":"Antibiotic resistance of Helicobacter pylori in Mainland China: a focus on geographic differences through systematic review and meta-analysis","volume":"64","author":"Zeng","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.108018_bib0016","doi-asserted-by":"crossref","DOI":"10.1111\/hel.70101","article-title":"Antibiotic combinations in bismuth-containing quadruple therapy for Helicobacter pylori eradication: a systematic review and network meta-analysis","volume":"30","author":"Duan","year":"2025","journal-title":"Helicobacter"},{"key":"10.1016\/j.ijantimicag.2026.108018_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2025.101217","article-title":"Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study","volume":"7","author":"Mart\u00ednez-Mart\u00ednez","year":"2026","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ijantimicag.2026.108018_bib0018","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrgastro.2010.210","article-title":"Optimal therapy for Helicobacter pylori infections","volume":"8","author":"Rimbara","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ijantimicag.2026.108018_bib0019","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ueg2.12569","article-title":"Role of compliance in Helicobacter pylori eradication treatment: results of the European Registry on H. pylori management","volume":"12","author":"Huguet","year":"2024","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.ijantimicag.2026.108018_bib0020","doi-asserted-by":"crossref","DOI":"10.1111\/hel.70056","article-title":"Vonoprazan improves efficacy of Bismuth Quadruple therapy for Helicobacter pylori rescue treatment: a multicenter randomized controlled trial","volume":"30","author":"Yan","year":"2025","journal-title":"Helicobacter"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926003055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926003055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:22:03Z","timestamp":1793305323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926003055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0924857926003055"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.108018","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of P-CABs-based bismuth quadruple therapy for first-line Helicobacter pylori eradication: A real-world evidence study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.108018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108018"}}